Indicatrix Crystallography Ltd. has completed spin-out negotiations with Newcastle University and is now available for business. Contract small molecule crystallisation and single crystal X-ray analysis projects now available. Check out our Services page or our listings on Scientist.com and ScienceExchange.com.
Indicatrix shortlisted for RSC Emerging Technologies 2020
Indicatrix Crystallography is selected by the Royal Society of Chemistry (@RoySocChem) as one of 6 finalists in the Heath category for the prestigious Emerging Technologies Competition 2020.
https://www.rsc.org/competitions/emerging-technologies/2020-finalists-and-winners/
ENaCt technology highlighted in Pharma Technology Focus
The potential impact of our crystallisation technology in the pharmaceutical sector is discussed in an article in Pharma Technology Focus
HOW A NEW CRYSTALLOGRAPHY TECHNIQUE MAY SPEED UP DRUG DEVELOPMENT
Encapsulated Nanodroplet Technology in Chem
Our patent pending Encapsulated Nanodroplet Technology (ENaCt) has been published in the Cell Press journal Chem
Indicatrix Crystallography – coming soon
Indicatrix Crystallography to commence trading in August 2020
Nanodroplet encapsulation technique crystallises the ‘uncrystallisable’
Our cutting edge ENaCt technology is highlighted in the Royal Society of Chemistry’s Chemistry World.
Nanodroplet encapsulation technique crystallises the ‘uncrystallisable’